IL81568A0 - Plasmids which inhibit human t-cell lymphotropic virus type iii replication - Google Patents

Plasmids which inhibit human t-cell lymphotropic virus type iii replication

Info

Publication number
IL81568A0
IL81568A0 IL81568A IL8156887A IL81568A0 IL 81568 A0 IL81568 A0 IL 81568A0 IL 81568 A IL81568 A IL 81568A IL 8156887 A IL8156887 A IL 8156887A IL 81568 A0 IL81568 A0 IL 81568A0
Authority
IL
Israel
Prior art keywords
plasmids
type iii
virus type
inhibit human
lymphotropic virus
Prior art date
Application number
IL81568A
Other languages
English (en)
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Publication of IL81568A0 publication Critical patent/IL81568A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL81568A 1986-02-14 1987-02-13 Plasmids which inhibit human t-cell lymphotropic virus type iii replication IL81568A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82951786A 1986-02-14 1986-02-14

Publications (1)

Publication Number Publication Date
IL81568A0 true IL81568A0 (en) 1987-09-16

Family

ID=25254758

Family Applications (1)

Application Number Title Priority Date Filing Date
IL81568A IL81568A0 (en) 1986-02-14 1987-02-13 Plasmids which inhibit human t-cell lymphotropic virus type iii replication

Country Status (6)

Country Link
EP (1) EP0233764A1 (fr)
JP (1) JPS63502161A (fr)
AU (1) AU594444B2 (fr)
IL (1) IL81568A0 (fr)
NZ (1) NZ219313A (fr)
WO (1) WO1987005048A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604114A (en) * 1986-05-20 1997-02-18 Dana-Farber Cancer Institute Cis-acting repression sequences, cis-acting antirepression sequences, vectors, methods of preparation and use
ATE126534T1 (de) * 1987-05-29 1995-09-15 Dana Farber Cancer Inst Inc Cis-wirkung-repressionen-sequenzen, cis-wirkung- antirepressionen-sequenzen, vektoren, verfahren zur vorbereitung und anwendung.
FR2621924B1 (fr) * 1987-10-19 1990-01-12 Pasteur Institut Gene recombinant, notamment retrovirus recombinant defectif et activable par un transactivateur, cellules les contenant, leur procede de fabrication et leurs applications, notamment pour la detection in vitro d'une infection retrovirale ou de l'etude de l'inhibition in vitro de l'infection par des principes actifs de medicaments
ATE208813T1 (de) * 1988-02-16 2001-11-15 Greatbatch Gen Aid Ltd Modifizierte zellen mit resistenz gegen retroviralinfektionen
GB8808892D0 (en) * 1988-04-15 1988-05-18 British Bio Technology Gene synthesis
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
US5278042A (en) * 1989-02-06 1994-01-11 The United States Of America As Represented By The Department Of Health & Human Services Method for detecting inhibitors of tat protein
WO1991018454A1 (fr) * 1990-05-18 1991-11-28 Centre National De La Recherche Scientifique Compositions capables de bloquer la cytotoxicite de proteines regulatrices de virus et les symptomes neurotoxiques associes aux infections par retrovirus
WO1991019795A1 (fr) * 1990-06-19 1991-12-26 Immuvax Variantes de virus non pathognes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4738922A (en) * 1984-05-25 1988-04-19 Dana Farber Cancer Institute Trans-acting transcriptional factors

Also Published As

Publication number Publication date
AU594444B2 (en) 1990-03-08
WO1987005048A1 (fr) 1987-08-27
JPS63502161A (ja) 1988-08-25
NZ219313A (en) 1989-01-27
EP0233764A1 (fr) 1987-08-26
AU7084487A (en) 1987-09-09

Similar Documents

Publication Publication Date Title
HU896283D0 (en) Colon-selective, peroral medical preparation
EP0402955A3 (fr) Instrument pour administrer des produits pharmaceutiques en pastilles.
GB8610572D0 (en) Pharmaceutical preparation
GB8716904D0 (en) Stable pharmaceutical preparation
GR3001214T3 (en) Fluorinated nucleosides,their preparation and their pharmaceutical use against aids
JPS6425800A (en) T-cell epitope of hepatities b virus nucleocapside protein
GB8618847D0 (en) Pharmaceutical formulations
IL93927A0 (en) Replication competent human immunodeficiency type 2 proviral clone
GB8726770D0 (en) Wheelchair restraints
IL81568A0 (en) Plasmids which inhibit human t-cell lymphotropic virus type iii replication
ZA862351B (en) Drug,preparation and use thereof
ZA872532B (en) Combined vaccine
ZA879023B (en) Conjugate vaccine
EP0266401A4 (fr) Vaccin.
ZA899948B (en) Pharmaceutical preparation
ZA872140B (en) Microlide compounds,their preparation and their use
ZA883878B (en) Human immunodeficiency virus gag-encoded proteins
GR871915B (en) Pharmaceutical formulations
GB2213062B (en) Pharmaceutical preparation having oestrogen action.
ZA877167B (en) Phosphorylated acylglycosides,their preparation and use
GB8802391D0 (en) Medicinal formulations
CS727386A1 (en) Zpusob zpracovani odpadnich olejovych kalu s obsahem kovu, zejmena medi, a zarizeni k provadeni tohoto zpusobu
CS727286A1 (en) Zpusob zpracovani odpadnich olejovych kalu s obsahem medi a zarizeni k provadeni tohoto zpusobu
GB8608991D0 (en) Virus vaccine
GR3003377T3 (en) Virus vaccine